Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment and enhancing ...
"Full House" star Dave Coulier revealed this week that he is cancer-free after undergoing chemotherapy following a diagnosis ...
Treatment of B-cell Acute Lymphoblastic Leukaemia has improved thanks to CAR-T therapies, but relapse is still very common.
If preclinical findings were translated into the clinic, they could shorten the CAR-T generation lead time from two weeks to ...
Bispecific antibodies have become component in the arsenal of treatments for hematologic malignancies; management of their side effects is crucial to their success.
News Medical on MSN12d
Researchers develop TIM-3 decoy to enhance CAR-T therapy effectiveness for B-ALL tumorsB-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...
B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback